Table 1 Correlations between miR-29c-3p with clinicopathological features of HCC patients

From: miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma

Variables

n

miR-29c-3p expression

P

Low (n = 95)

High (n = 55)

Age (years)

  <50

82

53

29

0.736

  ≥50

68

42

26

 

Gender

  Male

92

57

35

0.659

  Female

58

38

20

 

Tumor size (cm)

  ≤5

76

41

35

0.018

  >5

74

54

20

 

AFP (ng/mL)

  ≤20

69

48

21

0.175

  >20

81

47

34

 

Liver cirrhosis

  Presence

85

55

30

0.734

  Absence

65

40

25

 

HBsAg

  Positive

94

61

33

0.726

  Negative

56

34

22

 

TNM stage

  I/II

91

53

38

0.120

  III/IV

59

42

17

 

Vascular invasion

  Presence

74

43

31

0.236

  Absence

76

52

24

 

Multiplicity

  Single

71

37

34

0.011

  Multiple (≥2)

79

58

21

 

Intrahepatic metastasis

  Presence

85

60

25

0.035

  Absence

65

35

30

 
  1. HCC hepatocellular carcinoma, AFP alpha-fetoprotein, HBsAg hepatitis B surface antigen,TNM tumor, node, metastasis
  2. Bold values indicate statistical significance
Back to article page